Login / Signup

Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study.

Annamaria CattaneoClarissa FerrariLorinda TurnerNicole MarianiDaniela EnacheCaitlin HastingsMelisa KoseGiulia LombardoAnna P McLaughlinMaria A NettisNaghmeh NikkheslatLuca SforziniCourtney WorrellZuzanna ZajkowskaNadia CattaneNicola LopizzoMonica MazzelliLinda PointonPhilip J CowenJonathan CavanaghNeil A HarrisonPeter de BoerDeclan JonesWayne C DrevetsValeria MondelliEdward T Bullmorenull nullCarmine Maria Pariante
Published in: Translational psychiatry (2020)
We have corrected this Article post-publication, because Dr. Cattaneo's affiliation details were originally incorrect (she was affiliated with three institutions but is in fact only linked to one: Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia). These changes reflect in both the PDF and HTML versions of this Article.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • poor prognosis
  • patient reported
  • electronic health record
  • adverse drug
  • candida albicans